Safety and efficacy of canagliflozin in Japanese patients with type 2 diabetes mellitus:post hocsubgroup analyses according to body mass index in a 52-week open-label study

2015 ◽  
Vol 16 (11) ◽  
pp. 1577-1591 ◽  
Author(s):  
Nobuya Inagaki ◽  
Maki Goda ◽  
Shoko Yokota ◽  
Nobuko Maruyama ◽  
Hiroaki Iijima
Keyword(s):  
Type 2 Diabetes ◽  
Body Mass Index ◽  
Body Mass ◽  
Japanese Patients ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Safety And Efficacy

scholarly journals Ipragliflozin Add-on Therapy to a GLP-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes (AGATE): A 52-Week Open-Label Study

2018 ◽  
Vol 9 (4) ◽  
pp. 1549-1567 ◽  
Author(s):  
Hisamitsu Ishihara ◽  
Susumu Yamaguchi ◽  
Ikko Nakao ◽  
Taishi Sakatani
Keyword(s):  
Type 2 Diabetes ◽  
Receptor Agonist ◽  
Japanese Patients ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

scholarly journals Dapagliflozin as Monotherapy or Combination Therapy in Japanese Patients with Type 2 Diabetes: an Open-Label Study

2014 ◽  
Vol 5 (2) ◽  
pp. 415-433 ◽  
Author(s):  
Kohei Kaku ◽  
Hiroshi Maegawa ◽  
Yukio Tanizawa ◽  
Arihiro Kiyosue ◽  
Yumiko Ide ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Combination Therapy ◽  
Japanese Patients ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

Assessing the safety and efficacy of ruxolitinib in a multicenter, open-label study in Japanese patients with myelofibrosis

2016 ◽  
Vol 105 (3) ◽  
pp. 309-317 ◽  
Author(s):  
Norio Komatsu ◽  
Keita Kirito ◽  
Kazuya Shimoda ◽  
Takayuki Ishikawa ◽  
Kohshi Ohishi ◽  
...  
Keyword(s):  
Japanese Patients ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Safety And Efficacy

Self-reported rate of eating is significantly associated with body mass index in Japanese patients with type 2 diabetes. Japan Diabetes Clinical Data Management Study Group (JDDM26)

Appetite ◽  
2012 ◽  
Vol 59 (2) ◽  
pp. 252-255 ◽  
Author(s):  
Aki Saito ◽  
Koichi Kawai ◽  
Morifumi Yanagisawa ◽  
Hiroki Yokoyama ◽  
Nobuichi Kuribayashi ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Body Mass Index ◽  
Data Management ◽  
Body Mass ◽  
Clinical Data ◽  
Japanese Patients ◽  
Study Group ◽  
Management Study
Sign in / Sign up

Export Citation Format

Share Document